Involvement of tissue inhibitors of metalloproteinases (TIMPs) during matrix metalloproteinase activation

Advances in Experimental Medicine and Biology

Volumn 389, Issue , 1996, Pages 23-31

  Nagase, H ^a   Suzuki, K ^a   Itoh, Y ^a   Kan, C C ^b   Gehring, M R ^b   Huang, W ^c   Brew, K ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b AGOURON PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; GELATINASE; GLYCOPROTEIN; METALLOPROTEINASE; PROGELATINASE; PROSTROMELYSIN; PROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; COLLAGENASE;

ANIMAL; CHEMISTRY; ENZYME ACTIVATION; HUMAN; METABOLISM; REVIEW; BINDING AFFINITY; CONFERENCE PAPER; ENZYME BINDING; ENZYME INHIBITION; ENZYME MECHANISM; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATINASES; GLYCOPROTEINS; HUMANS; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0030339578     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0335-0_3     Document Type: Article

References (37)

1. Bányai, M. J., Tordai, H., and Patthy, L., 1994, The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A), Biochem. J. 298:403-407.
2. Birkedal-Hansen, H., Moore, W. G. I., Bodden, M.D., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A., 1993, Matrix metalloproteinases: a review, Crit. Rev. Oral Biol. Med. 4:197-250.
3. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines, Cancer Res. 50:6184-6191.
4. Collier, I. E., Krasnov, P. A., Strongin, A. Y., Birkedal-Hansen, H., and Goldberg, G. I., 1992, Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase, J. Biol. Chem. 267:6776-6781.
5. Crabbe, T., Willenbrock, F., Eaton, D., Hynds, P., Carne, A. K., Murphy, G., and Docherty, A. J. P., 1992, Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases, Biochemistry, 31:8500-8507.
6. Crabbe, T., O'Connell, J. P., Smith, B. J., and Docherty, A. J. P., 1994, Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase A, Biochemistry 33:14419-14425.
7. Freije, J. M. P., Diez-Itza, I., Balbin, M., Sánchez, L. M., Blasco, R., Tolivia, J., and López-Otín, C., 1994, Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas, J. Mol. Chem. 269:16766-16773.
8. Fridman, R., Fuerst, T. R., Bird, R. F., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta L. A., Berman, M. L., and Stetler-Stevenson, W. G., 1992, Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions, J. Biol. Chem. 267:15398-15404.
9. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., and Marmer, B. L., 1992, Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin, J. Biol. Chem. 267:4583-4591.
10. Holz, R. C., Salowe, S. P., Smith, C. K., Cuca, G. C., and Que L., Jr., 1992, EXAFS evidence for a "cysteine switch" in the activation of prostromelysin, J. Am. Chem. Soc. 114:9611-9614.
11. Howard, E. W., and Banda, M. J., 1991, Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase, J. Biol. Chem. 266:17972-17977.
12. Knäuper, V., Wilhelm, S. M., Seperack, P. K., DeClerck, Y. A., Langley, K. E., Osthues, A., and Tschcsche, H., 1993, Direct activation of human neutrophil procollagenase by recombinant stromelysin, Biochem. J. 295:581-586.
13. r active forms, and a comparison of recombinant with natural stromelysin activities, Biochem. J. 276:217-221.
14. Morodomi, T., Ogata, Y., Sasaguri, Y., Morimatsu, M., and Nagase, H., 1992, Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukemia and HT1080 fibrosarcoma cells, Biochem. J. 285:603-611.
15. Murphy G., Houbrechts, A., Cockett, M.I., Williamson, R. A., O'Shea, M., and Docherty, A. J. P., 1991, The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity, Biochemistry 30:8097-8102.
16. Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. F., Eaton, D., and Docherty, A. J. P., 1992, The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases, Biochem. J. 283:637-641.
17. Murphy, G., Segain, J.-P., O'Shea, M., Cockett, M., Ioannoum C., Lefebvre, O., Chambon, P., and Basset, P., 1993, The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase, J. Biol. Chem. 268:15435-15441.
18. Murphy, G., Nguyen, Q., Cockelt, M. I., Atkinson, S. J., Allen, J. A., Knight, G. C., Willenbrock, F., and Docherty, A. J. P., 1994, Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant, J. Biol. Chem. 269:6632-6636.
19. Nagase, H., Enghild, J. J., Suzuki, K., and Salvesen G., 1990, Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate, Biochemistry 39:5783-5789.
20. Ogata, Y., Enghild, J. J., and Nagase, H., 1992, Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9, J. Biol. Chem. 267:3581-3584.
21. Okada, Y., and Nakanishi, I., 1989. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ("gelatinase") by human neutrophil elastase and cathepsin G, FEBS Lett 249:353-356.
22. Okada, Y., Harris, E. D., Jr., Nagase, H., 1988, The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-amino-phenylmercuric acetate, Biochem. J. 254:731-741.
23. Okada, Y., Morodomi, T., Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H., 1990, Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties, Eur. J. Biochem. 194:721-730.
24. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T., 1992, Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267:21712-21719.
25. Overall, C. M., and Sodek, J., 1990, Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases, J. Biol. Chem. 265:21141-21151.
26. Pei, D., Majmudar, G., and Weiss, S. J., 1994, Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3, J. Biol. Chem. 269:25849-25855.
27. Salowe, S. P., Marcy, A. I., Cuca, G. C., Smith, C. K., Kopka, I. E., Hagmann, W. K., and Hermes, J. D., 1992, Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme, Biochemistry 31:4535-4540.
28. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M., 1994, A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
29. Shapiro, S. D., Kobayashi, D. K., and Ley, T. J., 1993, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages, J. Biol. Chem. 268:23824-23829.
30. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation, Proc. Natl. Acad. Sci. USA 87:364-368.
31. Suzuki, K., Enghild, J. J., Morodomi, T. Salvesen, G., and Nagase, H., 1990, Mechanisms of activation of tissue procollagenase by matrix metalloproteianse 3 (stromelysin), Biochemistry 29:10261-10270.
32. Suzuki, K., Lees, M., Newlands, G. F. J., Nagase, H., and Woolley, D. E., 1995, Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II, Biochem. J. 305:301-306.
33. Van Wart, H. E., and Birkedal-Hansen, H., 1990, The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc. Natl. Acad. Sci. USA 87:5578-5582.
34. Wilde, Craig G., Hawkins, P. R., Coleman, R. T., Levine, W. B., Delegeane, A. M., Okamoto, P. M., Ito, L. Y., Scott, R. W., and Seilhamer, J. J., 1994, Cloning and characterization of human tissue inhibitor of metalloproteinases-3, DNA Cell Biol. 13:711-718.
35. Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. J., 1989, SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213-17221.
36. Willenbrock, F., Crabbe, T., Slocombe, P. M., Sutton, C. W., Docherty, A. J. P., Cockett, M. I., O'Shea, M., Brocklehurst, K., Philips, I. R., and Murphy, G., 1993, The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A, Biochemistry 32, 4330-4337.
37. Woessner, J. F., Jr., 1991, Matrix metalloproteinaes and their inhibitors in connective tissue remodeling, FASEB J. 5:2145-2154.